{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T08:19:18Z","timestamp":1792657158273,"version":"4.5.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"7264","license":[{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1038\/nature08402","type":"journal-article","created":{"date-parts":[[2009,9,30]],"date-time":"2009-09-30T10:21:22Z","timestamp":1254306082000},"page":"659-663","source":"Crossref","is-referenced-by-count":371,"title":["Membrane-bound Fas ligand only is essential for Fas-induced apoptosis"],"prefix":"10.1038","volume":"461","author":[{"given":"Lorraine A.","family":"O\u2019 Reilly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Tai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lily","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A.","family":"Kruse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Grabow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Douglas","family":"Fairlie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole M.","family":"Haynes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Tarlinton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Guo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabrielle T.","family":"Belz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark J.","family":"Smyth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Bouillet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorraine","family":"Robb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Strasser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BFnature08402_CR1","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.immuni.2007.12.017","volume":"28","author":"PD Hughes","year":"2008","unstructured":"Hughes, P. D. et al. Apoptosis regulators Fas and Bim cooperate in shutdown of chronic immune responses and prevention of autoimmunity. Immunity 28, 197\u2013205 (2008)","journal-title":"Immunity"},{"key":"BFnature08402_CR2","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.immuni.2007.12.015","volume":"28","author":"J Hutcheson","year":"2008","unstructured":"Hutcheson, J. et al. Combined deficiency of proapoptotic regulators Bim and Fas results in the early onset of systemic autoimmunity. Immunity 28, 206\u2013217 (2008)","journal-title":"Immunity"},{"key":"BFnature08402_CR3","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.immuni.2007.12.014","volume":"28","author":"AE Weant","year":"2008","unstructured":"Weant, A. E. et al. Apoptosis regulators Bim and Fas function concurrently to control autoimmunity and CD8+ T\u2009cell contraction. Immunity 28, 218\u2013230 (2008)","journal-title":"Immunity"},{"key":"BFnature08402_CR4","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1038\/35037728","volume":"407","author":"PH Krammer","year":"2000","unstructured":"Krammer, P. H. CD95's deadly mission in the immune system. Nature 407, 789\u2013795 (2000)","journal-title":"Nature"},{"key":"BFnature08402_CR5","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.cell.2007.04.031","volume":"129","author":"ME Peter","year":"2007","unstructured":"Peter, M. E. et al. The CD95 receptor: apoptosis revisited. Cell 129, 447\u2013450 (2007)","journal-title":"Cell"},{"key":"BFnature08402_CR6","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.4049\/jimmunol.148.4.1274","volume":"148","author":"R Watanabe-Fukunaga","year":"1992","unstructured":"Watanabe-Fukunaga, R. et al. The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen. J. Immunol. 148, 1274\u20131279 (1992)","journal-title":"J. Immunol."},{"key":"BFnature08402_CR7","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/0092-8674(94)90375-1","volume":"76","author":"T Takahashi","year":"1994","unstructured":"Takahashi, T. et al. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 76, 969\u2013976 (1994)","journal-title":"Cell"},{"key":"BFnature08402_CR8","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1126\/science.7539157","volume":"268","author":"F Rieux-Laucat","year":"1995","unstructured":"Rieux-Laucat, F. et al. Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 268, 1347\u20131349 (1995)","journal-title":"Science"},{"key":"BFnature08402_CR9","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/0092-8674(95)90013-6","volume":"81","author":"GH Fisher","year":"1995","unstructured":"Fisher, G. H. et al. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 81, 935\u2013946 (1995)","journal-title":"Cell"},{"key":"BFnature08402_CR10","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/ni0503-399","volume":"4","author":"CM Trambas","year":"2003","unstructured":"Trambas, C. M. & Griffiths, G. M. Delivering the kiss of death. Nature Immunol. 4, 399\u2013403 (2003)","journal-title":"Nature Immunol."},{"key":"BFnature08402_CR11","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1038\/sj.cdd.4402101","volume":"14","author":"M Schulte","year":"2007","unstructured":"Schulte, M. et al. ADAM10 regulates FasL cell surface expression and modulates FasL-induced cytotoxicity and activation-induced cell death. Cell Death Differ. 14, 1040\u20131049 (2007)","journal-title":"Cell Death Differ."},{"key":"BFnature08402_CR12","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1084\/jem.187.8.1205","volume":"187","author":"P Schneider","year":"1998","unstructured":"Schneider, P. et al. Conversion of membrane-bound Fas(CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity. J. Exp. Med. 187, 1205\u20131213 (1998)","journal-title":"J. Exp. Med."},{"key":"BFnature08402_CR13","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/nm0198-031","volume":"4","author":"M Tanaka","year":"1998","unstructured":"Tanaka, M., Itai, T., Adachi, M. & Nagata, S. Downregulation of Fas ligand by shedding. Nature Med. 4, 31\u201336 (1998)","journal-title":"Nature Med."},{"key":"BFnature08402_CR14","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1084\/jem.191.7.1209","volume":"191","author":"AM Hohlbaum","year":"2000","unstructured":"Hohlbaum, A. M., Moe, S. & Marshak-Rothstein, A. Opposing effects of transmembrane and soluble Fas ligand expression on inflammation and tumor cell survival. J. Exp. Med. 191, 1209\u20131219 (2000)","journal-title":"J. Exp. Med."},{"key":"BFnature08402_CR15","doi-asserted-by":"publisher","first-page":"2354","DOI":"10.1126\/science.288.5475.2354","volume":"288","author":"RM Siegel","year":"2000","unstructured":"Siegel, R. M. et al. Fas preassociation required for apoptosis signaling and dominant inhibition by pathogenic mutations. Science 288, 2354\u20132357 (2000)","journal-title":"Science"},{"key":"BFnature08402_CR16","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1126\/science.282.5394.1714","volume":"282","author":"J-J Chen","year":"1998","unstructured":"Chen, J.-J., Sun, Y. & Nabel, G. J. Regulation of the proinflammatory effects of Fas ligand (CD95L). Science 282, 1714\u20131717 (1998)","journal-title":"Science"},{"key":"BFnature08402_CR17","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1038\/ni.1714","volume":"10","author":"NS Wilson","year":"2009","unstructured":"Wilson, N. S., Dixit, V. & Ashkenazi, A. Death receptor signal transducers: nodes of coordination in immune signaling networks. Nature Immunol. 10, 348\u2013355 (2009)","journal-title":"Nature Immunol."},{"key":"BFnature08402_CR18","doi-asserted-by":"publisher","first-page":"47100","DOI":"10.1074\/jbc.M107385200","volume":"276","author":"JH Ahn","year":"2001","unstructured":"Ahn, J. H. et al. Non-apoptotic signaling pathways activated by soluble Fas ligand in serum-starved human fibroblasts. Mitogen-activated protein kinases and NF-\u03baB-dependent gene expression. J. Biol. Chem. 276, 47100\u201347106 (2001)","journal-title":"J. Biol. Chem."},{"key":"BFnature08402_CR19","doi-asserted-by":"publisher","first-page":"50907","DOI":"10.1074\/jbc.M206093200","volume":"277","author":"S Xiao","year":"2002","unstructured":"Xiao, S., Jodo, S., Sung, S. S., Marshak-Rothstein, A. & Ju, S. T. A novel signaling mechanism for soluble CD95 ligand. Synergy with anti-CD95 monoclonal antibodies for apoptosis and NF-\u03baB nuclear translocation. J. Biol. Chem. 277, 50907\u201350913 (2002)","journal-title":"J. Biol. Chem."},{"key":"BFnature08402_CR20","doi-asserted-by":"publisher","first-page":"8953","DOI":"10.1073\/pnas.0702975104","volume":"104","author":"JB Oliveira","year":"2007","unstructured":"Oliveira, J. B. et al. NRAS mutation causes a human autoimmune lymphoproliferative syndrome. Proc. Natl Acad. Sci. USA 104, 8953\u20138958 (2007)","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnature08402_CR21","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1159\/000060497","volume":"1","author":"DH Kono","year":"1999","unstructured":"Kono, D. H. & Theofilopoulos, A. N. Genetic susceptibility to spontaneous lupus in mice. Curr. Dir. Autoimmun. 1, 72\u201398 (1999)","journal-title":"Curr. Dir. Autoimmun."},{"key":"BFnature08402_CR22","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/j.1460-2075.1995.tb06970.x","volume":"14","author":"D Watanabe","year":"1995","unstructured":"Watanabe, D., Suda, T., Hashimoto, H. & Nagata, S. Constitutive activation of the Fas ligand gene in mouse lymphoproliferative disorders. EMBO J. 14, 12\u201318 (1995)","journal-title":"EMBO J."},{"key":"BFnature08402_CR23","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1038\/364806a0","volume":"364","author":"J Ogasawara","year":"1993","unstructured":"Ogasawara, J. et al. Lethal effect of the anti-Fas antibody in mice. Nature 364, 806\u2013809 (1993)","journal-title":"Nature"},{"key":"BFnature08402_CR24","doi-asserted-by":"publisher","first-page":"14871","DOI":"10.1073\/pnas.96.26.14871","volume":"96","author":"DC Huang","year":"1999","unstructured":"Huang, D. C. et al. Activation of Fas by FasL induces apoptosis by a mechanism that cannot be blocked by Bcl-2 or Bcl-xL . Proc. Natl Acad. Sci. USA 96, 14871\u201314876 (1999)","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnature08402_CR25","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1038\/nm1296-1361","volume":"2","author":"S Strand","year":"1996","unstructured":"Strand, S. et al. Lymphocyte apoptosis induced by CD95 (APO-1\/Fas) ligand-expressing tumor cells\u2014a mechanism of immune evasion? Nature Med. 2, 1361\u20131366 (1996)","journal-title":"Nature Med."},{"key":"BFnature08402_CR26","volume-title":"Atlas of Mouse Hematopathology","author":"TN Fredrickson","year":"2000","unstructured":"Fredrickson, T. N. & Harris, A. W. Atlas of Mouse Hematopathology (Harwood Academic, 2000)"},{"key":"BFnature08402_CR27","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1093\/geronj\/36.5.534","volume":"36","author":"CH Frith","year":"1981","unstructured":"Frith, C. H. & Wiley, L. D. Morphologic classification and correlation of incidence of hyperplastic and neoplastic hematopoietic lesions in mice with age. J. Gerontol. 36, 534\u2013545 (1981)","journal-title":"J. Gerontol."},{"key":"BFnature08402_CR28","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1084\/jem.187.1.123","volume":"187","author":"I Suzuki","year":"1998","unstructured":"Suzuki, I. & Fink, P. J. Maximal proliferation of cytotoxic T lymphocytes requires reverse signaling through Fas ligand. J. Exp. Med. 187, 123\u2013128 (1998)","journal-title":"J. Exp. Med."},{"key":"BFnature08402_CR29","doi-asserted-by":"publisher","first-page":"4307","DOI":"10.4049\/jimmunol.179.7.4307","volume":"179","author":"M Sun","year":"2007","unstructured":"Sun, M. & Fink, P. J. A new class of reverse signaling costimulators belongs to the TNF family. J. Immunol. 179, 4307\u20134312 (2007)","journal-title":"J. Immunol."},{"key":"BFnature08402_CR30","doi-asserted-by":"publisher","first-page":"2118","DOI":"10.4049\/jimmunol.172.4.2118","volume":"172","author":"S Karray","year":"2004","unstructured":"Karray, S. et al. Complete loss of Fas ligand gene causes massive lymphoproliferation and early death, indicating a residual activity of gld allele. J. Immunol. 172, 2118\u20132125 (2004)","journal-title":"J. Immunol."},{"key":"BFnature08402_CR31","doi-asserted-by":"publisher","first-page":"5080","DOI":"10.1093\/nar\/23.24.5080","volume":"23","author":"F Schwenk","year":"1995","unstructured":"Schwenk, F., Baron, U. & Rajewsky, K. A cre-transgenic mouse strain for the ubiquitous deletion of loxP-flanked gene segments including deletion in germ cells. Nucleic Acids Res. 23, 5080\u20135081 (1995)","journal-title":"Nucleic Acids Res."},{"key":"BFnature08402_CR32","doi-asserted-by":"publisher","first-page":"634","DOI":"10.2337\/db06-0832","volume":"56","author":"JM Phillips","year":"2007","unstructured":"Phillips, J. M., O'Reilly, L., Bland, C., Foulis, A. K. & Cooke, A. Patients with chronic pancreatitis have islet progenitor cells in their ducts, but reversal of overt diabetes in NOD mice by anti-CD3 shows no evidence for islet regeneration. Diabetes 56, 634\u2013640 (2007)","journal-title":"Diabetes"},{"key":"BFnature08402_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1046\/j.1365-2559.2002.01418.x","volume":"41","author":"SA Pileri","year":"2002","unstructured":"Pileri, S. A. et al. Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases. Histopathology 41, 1\u201329 (2002)","journal-title":"Histopathology"},{"key":"BFnature08402_CR34","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1242\/jcs.114.13.2405","volume":"114","author":"EJ Blott","year":"2001","unstructured":"Blott, E. J., Bossi, G., Clark, R., Zvelebil, M. & Griffiths, G. M. Fas ligand is targeted to secretory lysosomes via a proline-rich domain in its cytoplasmic tail. J. Cell Sci. 114, 2405\u20132416 (2001)","journal-title":"J. Cell Sci."},{"key":"BFnature08402_CR35","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1182\/blood-2002-10-3186","volume":"102","author":"S Naik","year":"2003","unstructured":"Naik, S., Vremec, D., Wu, L., O'Keeffe, M. & Shortman, K. CD8\u03b1+ mouse spleen dendritic cells do not originate from the CD8 \u03b1-dendritic cell subset. Blood 102, 601\u2013604 (2003)","journal-title":"Blood"},{"key":"BFnature08402_CR36","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/0092-8674(95)90171-X","volume":"83","author":"ML Hibbs","year":"1995","unstructured":"Hibbs, M. L. et al. Multiple defects in the immune system of Lyn-deficient mice, culminating in autoimmune disease. Cell 83, 301\u2013311 (1995)","journal-title":"Cell"},{"key":"BFnature08402_CR37","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/0022-1759(94)90236-4","volume":"171","author":"AB Lyons","year":"1994","unstructured":"Lyons, A. B. & Parish, C. R. Determination of lymphocyte division by flow cytometry. J. Immunol. Methods 171, 131\u2013137 (1994)","journal-title":"J. Immunol. Methods"},{"key":"BFnature08402_CR38","first-page":"643","volume":"41","author":"ED Kilbourne","year":"1969","unstructured":"Kilbourne, E. D. Future influenza vaccines and the use of genetic recombinants. Bull. WHO 41, 643\u2013645 (1969)","journal-title":"Bull. WHO"},{"key":"BFnature08402_CR39","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/S1074-7613(00)80573-7","volume":"8","author":"KJ Flynn","year":"1998","unstructured":"Flynn, K. J. et al. Virus-specific CD8+ T\u2009cells in primary and secondary influenza pneumonia. Immunity 8, 683\u2013691 (1998)","journal-title":"Immunity"},{"key":"BFnature08402_CR40","doi-asserted-by":"publisher","first-page":"3486","DOI":"10.1128\/JVI.74.8.3486-3493.2000","volume":"74","author":"GT Belz","year":"2000","unstructured":"Belz, G. T., Xie, W., Altman, J. D. & Doherty, P. C. A previously unrecognized H-2D(b)-restricted peptide prominent in the primary influenza A virus-specific CD8(+) T-cell response is much less apparent following secondary challenge. J. Virol. 74, 3486\u20133493 (2000)","journal-title":"J. Virol."},{"key":"BFnature08402_CR41","doi-asserted-by":"publisher","first-page":"4627","DOI":"10.4049\/jimmunol.166.7.4627","volume":"166","author":"GT Belz","year":"2001","unstructured":"Belz, G. T., Xie, W. & Doherty, P. C. Diversity of epitope and cytokine profiles for primary and secondary influenza a virus-specific CD8+ T\u2009cell responses. J. Immunol. 166, 4627\u20134633 (2001)","journal-title":"J. Immunol."}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nature08402.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nature08402","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nature08402.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,16]],"date-time":"2024-03-16T17:26:54Z","timestamp":1710610014000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nature08402"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":41,"journal-issue":{"issue":"7264","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["BFnature08402"],"URL":"https:\/\/doi.org\/10.1038\/nature08402","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1165552.751108","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.1165552.746056","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.1165552.628558","asserted-by":"object"}]},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,10]]}}}